Exact Mass: 375.2171

Exact Mass Matches: 375.2171

Found 171 metabolites which its exact mass value is equals to given mass value 375.2171, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Phe-Pro-Ile

2-({[1-(2-amino-3-phenylpropanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-methylpentanoic acid

C20H29N3O4 (375.2158)

Bacithrocin B 2

C19H29N5O3 (375.227)

RCS-8

1-(1-(2-cyclohexylethyl)-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone

C25H29NO2 (375.2198)

pyrrole-2-carboxylic acid 9-hydroxymethyl-7-(6-oxo-piperidin-2-yl)-octahydro-quinolizin-2-yl ester

C20H29N3O4 (375.2158)

Ala Ala Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O6 (375.2118)

Ala Ala Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O6 (375.2118)

Ala Gly Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]-3-hydroxybutanoic acid

C15H29N5O6 (375.2118)

Ala Gly Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxybutanamido]hexanoic acid

C15H29N5O6 (375.2118)

Ala Lys Ala Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]propanamido]-3-hydroxypropanoic acid

C15H29N5O6 (375.2118)

Ala Lys Gly Thr

(2S,3R)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}-3-hydroxybutanoic acid

C15H29N5O6 (375.2118)

Ala Lys Ser Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxypropanamido]propanoic acid

C15H29N5O6 (375.2118)

Ala Lys Thr Gly

2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxybutanamido]acetic acid

C15H29N5O6 (375.2118)

Ala Ser Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]propanamido]hexanoic acid

C15H29N5O6 (375.2118)

Ala Ser Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]hexanamido]propanoic acid

C15H29N5O6 (375.2118)

Ala Thr Gly Lys

(2S)-6-amino-2-{2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]acetamido}hexanoic acid

C15H29N5O6 (375.2118)

Ala Thr Lys Gly

2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]hexanamido]acetic acid

C15H29N5O6 (375.2118)

Gly Ala Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]-3-hydroxybutanoic acid

C15H29N5O6 (375.2118)

Gly Ala Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxybutanamido]hexanoic acid

C15H29N5O6 (375.2118)

Gly Lys Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]-3-hydroxybutanoic acid

C15H29N5O6 (375.2118)

Gly Lys Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxybutanamido]propanoic acid

C15H29N5O6 (375.2118)

Gly Thr Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]propanamido]hexanoic acid

C15H29N5O6 (375.2118)

Gly Thr Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]hexanamido]propanoic acid

C15H29N5O6 (375.2118)

Leu Phe Pro

C20H29N3O4 (375.2158)

Leu Met Ile

C17H33N3O4S1 (375.2192)

Lys Gln Thr

C15H29N5O6 (375.2118)

Ile Phe Pro

C20H29N3O4 (375.2158)

Pro Phe Leu

C20H29N3O4 (375.2158)

Pro Leu Phe

C20H29N3O4 (375.2158)

Lys Ala Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]propanamido]-3-hydroxypropanoic acid

C15H29N5O6 (375.2118)

Lys Ala Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]acetamido}-3-hydroxybutanoic acid

C15H29N5O6 (375.2118)

Lys Ala Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]propanoic acid

C15H29N5O6 (375.2118)

Lys Ala Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxybutanamido]acetic acid

C15H29N5O6 (375.2118)

Met Leu Ile

C17H33N3O4S1 (375.2192)

Lys Gly Ala Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}propanamido]-3-hydroxybutanoic acid

C15H29N5O6 (375.2118)

Lys Gly Thr Ala

(2S)-2-[(2S,3R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxybutanamido]propanoic acid

C15H29N5O6 (375.2118)

Thr Gln Lys

C15H29N5O6 (375.2118)

Lys Ser Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]propanoic acid

C15H29N5O6 (375.2118)

Lys Thr Ala Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]propanamido]acetic acid

C15H29N5O6 (375.2118)

Lys Thr Gly Ala

(2S)-2-{2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]acetamido}propanoic acid

C15H29N5O6 (375.2118)

Phe Pro Leu

C20H29N3O4 (375.2158)

Leu Ile Met

C17H33N3O4S1 (375.2192)

Ile Leu Met

C17H33N3O4S1 (375.2192)

Met Leu Leu

C17H33N3O4S1 (375.2192)

Ile Met Ile

C17H33N3O4S1 (375.2192)

Leu Met Leu

C17H33N3O4S1 (375.2192)

Met Ile Ile

C17H33N3O4S1 (375.2192)

Gln Lys Thr

C15H29N5O6 (375.2118)

Ile Met Leu

C17H33N3O4S1 (375.2192)

Leu Pro Phe

C20H29N3O4 (375.2158)

Gln Thr Lys

C15H29N5O6 (375.2118)

Ile Ile Met

C17H33N3O4S1 (375.2192)

Ser Ala Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]propanamido]hexanoic acid

C15H29N5O6 (375.2118)

Ser Ala Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]hexanamido]propanoic acid

C15H29N5O6 (375.2118)

Ser Lys Ala Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]propanamido]propanoic acid

C15H29N5O6 (375.2118)

Phe Ile Pro

C20H29N3O4 (375.2158)

Thr Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]acetamido}hexanoic acid

C15H29N5O6 (375.2118)

Thr Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]hexanamido]acetic acid

C15H29N5O6 (375.2118)

Phe Leu Pro

C20H29N3O4 (375.2158)

Thr Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}propanamido]hexanoic acid

C15H29N5O6 (375.2118)

Thr Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}hexanamido]propanoic acid

C15H29N5O6 (375.2118)

Met Ile Leu

C17H33N3O4S1 (375.2192)

Thr Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]propanamido]acetic acid

C15H29N5O6 (375.2118)

Thr Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]acetamido}propanoic acid

C15H29N5O6 (375.2118)

Leu Leu Met

C17H33N3O4S1 (375.2192)

ENMD-2076

C21H25N7 (375.2171)

6-Benzyl 2-tert-butyl 2,6,9-triazaspiro[4.5]decane-2,6-dicarboxylate

C20H29N3O4 (375.2158)

Prenoverine

C25H29NO2 (375.2198)

TERT-BUTYL 4-(1-(BENZYLOXYCARBONYL)AZETIDIN-3-YL)PIPERAZINE-1-CARBOXYLATE

C20H29N3O4 (375.2158)

Difeterol

2-[2-benzhydryloxyethyl(methyl)amino]-1-phenylpropan-1-ol

C25H29NO2 (375.2198)

C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

9-Benzyl 2-Tert-Butyl 2,6,9-Triazaspiro[4.5]Decane-2,9-Dicarboxylate

C20H29N3O4 (375.2158)

p-cyanophenyl trans-p-(4-pentylcyclohexyl)benzoate

C25H29NO2 (375.2198)

tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,5-dihydro-2H-1,4-benzoxazepine-4-carboxylate

C20H30BNO5 (375.2217)

Jasmolin II

C22H31O5 (375.2171)

6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(Z)-2- phenylvinyl]-4-pyrimidinamine

C21H25N7 (375.2171)

benzyl 3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]azetidin-1-yl]pyrrolidine-1-carboxylate

C20H29N3O4 (375.2158)

(2r,6s)-6-{[methyl(3,4,5-Trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-Hexahydroquinazoline-2,4-Diamine

C19H29N5O3 (375.227)

resolvin D1(1-)

C22H31O5- (375.2171)

(4Z,7S,8E,10Z,12E,14E,16R,17S,19Z)-7,16,17-trihydroxydocosa-4,8,10,12,14,19-hexaenoate

C22H31O5- (375.2171)

aspirin triggered resolvin D1

C22H31O5- (375.2171)

aspirin triggered resolvin D3

C22H31O5- (375.2171)

(4S,5E,7Z,10Z,13Z,15E,17R,19Z)-4-hydroperoxy17-hydroxydocosa-5,7,10,13,15,19-hexaenoate

C22H31O5- (375.2171)

(4S,5E,7Z,10Z,13Z,15E,17S,19Z)-4-hydroperoxy-17-hydroxydocosa-5,7,10,13,15,19-hexaenoate

C22H31O5- (375.2171)

(4Z,7S,8E,10Z,13E,15Z,17S,19Z)7-hydroperoxy-17-hydroxydocosa-4,8,10,13,15,19-hexaenoate

C22H31O5- (375.2171)

(7S,17R)-17-hydroxy-7-hydroperoxydocosahexaenoate

C22H31O5- (375.2171)

4S,11R,17S-trihydroxy-5Z,7E,9E,13Z,15E,19Z-docosahexaenoate

C22H31O5- (375.2171)

aspirin triggered resolvin D2

C22H31O5- (375.2171)

4S,5R-17S-resolvin

C22H31O5- (375.2171)

aspirin triggered resolvin D4

C22H31O5- (375.2171)

Ile-Pro-Phe

C20H29N3O4 (375.2158)

1-[1-[(4-Hydroxy-1-piperidinyl)-oxomethyl]cyclohexyl]-3-(2-methoxyphenyl)urea

C20H29N3O4 (375.2158)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide

C20H29N3O4 (375.2158)

Pro-Leu-Phe

C20H29N3O4 (375.2158)

Leu-Leu-Met

C17H33N3O4S (375.2192)

Met-Leu-Leu

C17H33N3O4S (375.2192)

Phe-Leu-Pro

C20H29N3O4 (375.2158)

Leu-Pro-Phe

C20H29N3O4 (375.2158)

Phe-Pro-Leu

C20H29N3O4 (375.2158)

Phe-Pro-Ile

C20H29N3O4 (375.2158)

Leu-Met-Leu

C17H33N3O4S (375.2192)

Phe-Ile-Pro

C20H29N3O4 (375.2158)

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[(2-pyridin-4-ylacetyl)amino]ethyl]oxan-3-yl]cyclobutanecarboxamide

C20H29N3O4 (375.2158)

2-[(2S,3S,6R)-2-(hydroxymethyl)-3-(propylcarbamoylamino)-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide

C20H29N3O4 (375.2158)

2-[(2S,3S,6S)-2-(hydroxymethyl)-3-(propylcarbamoylamino)-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide

C20H29N3O4 (375.2158)

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[(1-oxo-2-pyridin-4-ylethyl)amino]ethyl]-3-oxanyl]cyclobutanecarboxamide

C20H29N3O4 (375.2158)

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[(1-oxo-2-pyridin-4-ylethyl)amino]ethyl]-3-oxanyl]cyclobutanecarboxamide

C20H29N3O4 (375.2158)

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[(2-pyridin-4-ylacetyl)amino]ethyl]oxan-3-yl]cyclobutanecarboxamide

C20H29N3O4 (375.2158)

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[(2-pyridin-4-ylacetyl)amino]ethyl]oxan-3-yl]cyclobutanecarboxamide

C20H29N3O4 (375.2158)

2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide

C20H29N3O4 (375.2158)

2-[(2S,3R,6S)-2-(hydroxymethyl)-3-(propylcarbamoylamino)-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide

C20H29N3O4 (375.2158)

2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide

C20H29N3O4 (375.2158)

2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide

C20H29N3O4 (375.2158)

2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide

C20H29N3O4 (375.2158)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide

C20H29N3O4 (375.2158)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide

C20H29N3O4 (375.2158)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide

C20H29N3O4 (375.2158)

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[(1-oxo-2-pyridin-4-ylethyl)amino]ethyl]-3-oxanyl]cyclobutanecarboxamide

C20H29N3O4 (375.2158)

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[(1-oxo-2-pyridin-4-ylethyl)amino]ethyl]-3-oxanyl]cyclobutanecarboxamide

C20H29N3O4 (375.2158)

2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-phenylethyl)acetamide

C20H29N3O4 (375.2158)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide

C20H29N3O4 (375.2158)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide

C20H29N3O4 (375.2158)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide

C20H29N3O4 (375.2158)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide

C20H29N3O4 (375.2158)

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(1-oxo-2-pyridin-4-ylethyl)amino]ethyl]-3-oxanyl]cyclobutanecarboxamide

C20H29N3O4 (375.2158)

Pro-phe-leu

C20H29N3O4 (375.2158)

Carmoxirole(1+)

C24H27N2O2+ (375.2072)

Ile-Ile-Met

C17H33N3O4S (375.2192)

Ile-Phe-Pro

C20H29N3O4 (375.2158)

Leu-Met-Ile

C17H33N3O4S (375.2192)

Lys-Thr-Gln

C15H29N5O6 (375.2118)

Met-Ile-Leu

C17H33N3O4S (375.2192)

Lys-Gln-Thr

C15H29N5O6 (375.2118)

Gln-Lys-Thr

C15H29N5O6 (375.2118)

Gln-Thr-Lys

C15H29N5O6 (375.2118)

Ile-Leu-Met

C17H33N3O4S (375.2192)

Ile-Met-Ile

C17H33N3O4S (375.2192)

Ile-Met-Leu

C17H33N3O4S (375.2192)

Leu-Ile-Met

C17H33N3O4S (375.2192)

Leu-Phe-Pro

C20H29N3O4 (375.2158)

Met-Ile-Ile

C17H33N3O4S (375.2192)

Met-Leu-Ile

C17H33N3O4S (375.2192)

Pro-Ile-Phe

C20H29N3O4 (375.2158)

Pro-Phe-Ile

C20H29N3O4 (375.2158)

Thr-Gln-Lys

C15H29N5O6 (375.2118)

Thr-Lys-Gln

C15H29N5O6 (375.2118)

10(R),17(S),20-trihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoate

C22H31O5- (375.2171)

4-[2,3-Di(butanoyloxy)propoxy]-2-(trimethylazaniumyl)butanoate

C18H33NO7 (375.2257)

4-(3-Acetyloxy-2-hexanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C18H33NO7 (375.2257)

4-(2-Pentanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C18H33NO7 (375.2257)

resolvin D2(1-)

C22H31O5 (375.2171)

A polyunsaturated fatty acid anion that is the conjugate base of resolvin D2, obtained by deprotonation of the carboxy group; major species at pH 7.3.

22-hydroxyprotectin D1(1-)

C22H31O5 (375.2171)

A docosanoid anion that is the conjugate base of 22-hydroxyprotectin D1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

LML134

C19H29N5O3 (375.227)

LML134 (compound 18b) is an orally active and high selective Histamine 3 receptor (H3R) inverse agonist with Kis of 0.3 nM and 12 nM for hH3R cAMP and hH3R bdg. LML134 penetrates the brain rapidly, leading to high H3R occupancy, and disengages its target with a fast kinetic profile. LML134 has the potential for excessive sleep disorders[1].

(2r,7r,9r,9as)-7-[(2r)-6-hydroxy-2,3,4,5-tetrahydropyridin-2-yl]-9-(hydroxymethyl)-octahydro-1h-quinolizin-2-yl 1h-pyrrole-2-carboxylate

C20H29N3O4 (375.2158)

(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(1-hydroxy-2-methylpropylidene)amino]-3-phenylpropanimidic acid

C19H29N5O3 (375.227)

7-(6-hydroxy-2,3,4,5-tetrahydropyridin-2-yl)-9-(hydroxymethyl)-octahydro-1h-quinolizin-2-yl 1h-pyrrole-2-carboxylate

C20H29N3O4 (375.2158)